Follow
Yuji Mano
Yuji Mano
Senior Director, DMPK, Eisai Co., Ltd.
Verified email at hhc.eisai.co.jp
Title
Cited by
Cited by
Year
Biochemical and pharmacological characterization of YM-60828, a newly synthesized and orally active inhibitor of human factor Xa
Y Taniuchi, Y Sakai, N Hisamichi, M Kayama, Y Mano, K Sato, ...
Thrombosis and haemostasis 79 (03), 543-548, 1998
1041998
Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance–associated protein 2
Y Mano, T Usui, H Kamimura
Biopharmaceutics & drug disposition 28 (1), 13-18, 2007
912007
Hematocrit-independent recovery is a key for bioanalysis using volumetric absorptive microsampling devices, MitraTM
Y Mano, K Kita, K Kusano
Bioanalysis 7 (15), 1821-1829, 2015
752015
The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver
Y Mano, T Usui, H Kamimura
Drug metabolism and disposition 35 (11), 2040-2044, 2007
712007
Investigation of the high partition of YM992, a novel antidepressant, in rat brain ‐ in vitro and in vivo evidence for the high binding in brain and the high …
Y Mano, S Higuchi, H Kamimura
Biopharmaceutics & drug disposition 23 (9), 351-360, 2002
502002
Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver
Y Mano, T Usui, H Kamimura
Drug metabolism and disposition 35 (7), 1182-1187, 2007
492007
Application of volumetric absorptive microsampling device for quantification of tacrolimus in human blood as a model drug of high blood cell partition
K Kita, Y Mano
Journal of Pharmaceutical and Biomedical Analysis 143, 168-175, 2017
482017
High-performance liquid chromatography–tandem mass spectrometry method for the determination of perampanel, a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid …
Y Mano, O Takenaka, K Kusano
Journal of Pharmaceutical and Biomedical Analysis 107, 56-62, 2015
402015
Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver
Y Mano, T Usui, H Kamimura
European journal of clinical pharmacology 63, 289-296, 2007
392007
Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes
Y Mano, T Usui, H Kamimura
European journal of clinical pharmacology 63, 211-216, 2007
372007
In vitro inhibitory effects of non‐steroidal anti‐inflammatory drugs on 4‐methylumbelliferone glucuronidation in recombinant human UDP‐glucuronosyltransferase …
Y Mano, T Usui, H Kamimura
Biopharmaceutics & drug disposition 27 (1), 1-6, 2006
332006
Effects of β‐estradiol and propofol on the 4‐methylumbelliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9
Y Mano, T Usui, H Kamimura
Biopharmaceutics & drug disposition 25 (8), 339-344, 2004
322004
Application of a volumetric absorptive microsampling device to a pharmacokinetic study of tacrolimus in rats: comparison with wet blood and plasma
K Kita, K Noritake, Y Mano
European Journal of Drug Metabolism and Pharmacokinetics 44, 91-102, 2019
312019
In Vitro inhibitory effects of non‐steroidal antiinflammatory drugs on UDP‐glucuronosyltransferase 1A1‐catalysed estradiol 3β‐glucuronidation in human liver …
Y Mano, T Usui, H Kamimura
Biopharmaceutics & drug disposition 26 (1), 35-39, 2005
312005
A validated LC–MS/MS method of total and unbound lenvatinib quantification in human serum for protein binding studies by equilibrium dialysis
Y Mano, K Kusano
Journal of pharmaceutical and biomedical analysis 114, 82-87, 2015
302015
Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes
Y Mano, T Usui, H Kamimura
Drug metabolism and disposition 35 (4), 602-606, 2007
302007
HPLC with fluorescence detection assay of perampanel, a novel AMPA receptor antagonist, in human plasma for clinical pharmacokinetic studies
Y Mano, O Takenaka, K Kusano
Biomedical Chromatography 29 (10), 1589-1593, 2015
272015
Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver
Y Mano, T Usui, H Kamimura
Pharmaceutical research 23, 1502-1508, 2006
222006
Method validation studies and an inter-laboratory cross validation study of lenvatinib assay in human plasma using LC-MS/MS
Y Mano
Practical Laboratory Medicine 12, e00103, 2018
192018
Species differences in inhibition potential of nonsteroidal anti-inflammatory drugs against estradiol 3β-glucuronidation between rats, dogs, and humans
Y Mano, T Usui, H Kamimura
Journal of pharmaceutical sciences 97 (7), 2805-2810, 2008
172008
The system can't perform the operation now. Try again later.
Articles 1–20